ADM
40
-2
UA
56
8
FOX
66
-4
AMZN
60
-9
CCI
34
13
PVH
48
-4
JBHT
33
-2
NOV
39
-3
GPC
51
-2
NVDA
71
-2
UNM
65
2
VNO
59
-2
LRCX
62
-2
AA
48
-3
MSFT
70
2
LOW
61
2
MLM
66
12
ICE
66
2
NWL
48
5
GOOGL
47
-11
ADM
40
-2
UA
56
8
FOX
66
-4
AMZN
60
-9
CCI
34
13
PVH
48
-4
JBHT
33
-2
NOV
39
-3
GPC
51
-2
NVDA
71
-2
UNM
65
2
VNO
59
-2
LRCX
62
-2
AA
48
-3
MSFT
70
2
LOW
61
2
MLM
66
12
ICE
66
2
NWL
48
5
GOOGL
47
-11
Financhill
Back

Verizon Communications Vs. Apellis Pharmaceuticals Industry Stock Comparison

Buy
64

VZ
Verizon Communications

Last Price:
$44.40
Seasonality Move:
1.14%
Sell
34

APLS
Apellis Pharmaceuticals

Last Price:
$17.46
Seasonality Move:
5.74%
Buy
64
Verizon Communications (VZ) is a Buy

Is Verizon Communications a Buy, Sell or Hold?

  • The current Verizon Communications [VZ] share price is $44.31. The Score for VZ is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
  • VZ is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
34
Apellis Pharmaceuticals (APLS) is a Sell

Is Apellis Pharmaceuticals a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals [APLS] share price is $17.67. The Score for APLS is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
  • APLS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

VZ Stock Price Chart

What is Verizon Communications's stock price today?

  • The Verizon Communications share price today is $44.31
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VZ is experiencing buying pressure, which is a positive indicator for future bullish movement.

APLS Stock Price Chart

What is Apellis Pharmaceuticals's stock price today?

  • The Apellis Pharmaceuticals share price today is $17.67
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing buying pressure, which is a positive indicator for future bullish movement.

VZ Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.05 Buy
Relative Strength Index (14 RSI): 56.48 Buy
Chaikin Money Flow: 11456664 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (42.72 - 44.08) Buy
Bollinger Bands (100): (39.97 - 44.13) Buy

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.92 Sell
Relative Strength Index (14 RSI): 42.41 Sell
Chaikin Money Flow: 2245169 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (17.12 - 19.16) Sell
Bollinger Bands (100): (19.76 - 30.34) Sell

VZ Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 43.38 Buy
20-day SMA: 43.28 Buy
50-day SMA: 43.67 Buy
200-day SMA: 42.18 Buy
8-day EMA: 43.56 Buy
20-day EMA: 43.46 Buy
50-day EMA: 43.24 Buy
200-day EMA: 42.05 Buy

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 17.26 Buy
20-day SMA: 18.04 Sell
50-day SMA: 20.55 Sell
200-day SMA: 28.95 Sell
8-day EMA: 17.47 Buy
20-day EMA: 18.18 Sell
50-day EMA: 20.5 Sell
200-day EMA: 29.11 Sell

Verizon Communications Earnings Growth & VZ Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.08 per share, an increase next quarter of $0.02 per share, an increase this year of $0.09 per share, and an increase next year of $0.13 per share.

Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.12 per share, an increase next quarter of $0.19 per share, a decrease this year of $0.19 per share, and an increase next year of $1.21 per share.

Verizon Communications Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Apellis Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):